In a highly innovative and competitive pharmaceutical world, the mantra of success is speed-of-launch and first-time-right formulation development. Our Closer to the Formulator (C2F) Center in Hyderabad, India aims to combine the in-depth excipient expertise of DFE Pharma with formulation development services to achieve the development goals of a formulator/researcher. From this center, we can provide end-to-end services or support in the segments required to bring drug products to market quickly and cost-effectively.
Our C2F formulation solutions include formulation development and optimization for all oral solid dosage forms such as tablets, capsules, granules, powders etc. The service also includes specialized dosage forms such as diffusion controlled and matrix extended release formulations, effervescent tablets, orally disintegrating tablets, sublingual tablets, minitablets and so on.
The final formulation advice contains the optimal excipient choice, ratio and processing parameters including scale up recommendations for customers’ dosage form. Using our excipient expertise and broad excipient portfolio, a variety of quality attributes of the desired dosage form can be optimized in the formulation process. The final reports contain a full description of the methodology that has been used, as well as the results generated during the formulation development studies.
We can also help our partners in achieving operational and/or cost efficiencies for existing commercialized products through approaches such as increasing speed of compression, converting a wet granulated product to direct compression etc.
The C2F Center contains fully equipped lab facilities where our experts work to develop customized formulations. The development efforts are not restricted to the DFE Pharma excipient but are selected as per drug product requirement. With an innovative concept of model API we can save considerably development time, ensure confidentiality of your API and ensure cost saving.
To receive more information about our C2F center, please get in touch.